IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $121 | -87.9% | 19 | -78.9% | 0.00% | – |
| Q2 2022 | $1,000 | -90.0% | 90 | -85.1% | 0.00% | -100.0% |
| Q1 2022 | $10,000 | -47.4% | 604 | -40.6% | 0.00% | -40.0% |
| Q4 2021 | $19,000 | +35.7% | 1,017 | +78.4% | 0.01% | -16.7% |
| Q3 2021 | $14,000 | +100.0% | 570 | +120.9% | 0.01% | +200.0% |
| Q2 2021 | $7,000 | -46.2% | 258 | -36.8% | 0.00% | -50.0% |
| Q1 2021 | $13,000 | +550.0% | 408 | +946.2% | 0.00% | +100.0% |
| Q4 2020 | $2,000 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |